抗肿瘤与促 TIL（肿瘤浸润淋巴细胞）在接受新辅助全身治疗的早期乳腺癌患者病理完全缓解中的可能作用

The tumor microenvironment, composed of pro- and antitumor immune cells, affects cancer cell behavior.

We aimed to evaluate whether tumor-infiltrating lymphocyte (TIL) density and TIL subtypes in core biopsies at the diagnosis of breast cancer patients could predict a pathologic complete response (pCR; ypT0/is ypN0) from neoadjuvant systemic therapy (NST). The TIL subtypes were determined based on the proportions of presumably antitumor (CD8+, CXCL13+) and protumor (PD-1+, FOXP3+) immune cells. A prospective, noninterventional study, including 171 participants undergoing NST, was performed. The median TIL density for the entire cohort was 10% (IQR: 3. 5-23. 8), and 59 (35%) patients achieved pCR. TIL density was positively associated with pCR (univariately and multivariably).

In the multivariable logistic regression model, TIL density was an independent predictor of pCR ( p = 0. 012, OR 1. 27; 95% CI 1. 05-1. 54) when controlled for age ( p = 0. 232), Ki-67 ( p = 0. 001), node-negative status ( p = 0. 024), and HER2+/triple negative vs. luminal B-like subtype ( p < 0. 001).

In our sample, higher proportions of PD-1+ TILs and FOXP3+ TILs were associated with a higher probability of pCR but the association was not statistically significant and we could not make any conclusions on the direction of associations in the model with all four biomarkers. In the exploratory multivariable analysis, we showed that only higher CD8+ TILs were associated with pCR.

In conclusion, TIL density and its subtypes are associated with pCR.